Table S1.
Rotational and translational diffusion of Ddx4
| Protein | Concentration | MW(kDa) | D(cm2/s)* | RH† | ‡ (ns) |
| Ubiquitin§ | 8.5 | 2.0 × 10−6 (0.1) | 15.7 | 3.3 | |
| 7 mg/mL¶ | 25.8 | 8.8 × 10−7 (0.2) | 31.6 | 1.5(0.5) | |
| # | 24.8 | 9.0 × 10−7 (0.1) | 30.9 | ‖ | |
| 250 mg/mL | 24.8 | 3.5 × 10−8 (0.1) | ** | 2.4(0.8) | |
| 370 mg/mL | 24.8 | 9.2 × 10−9 (0.9) | ** | 4.8(1.5) | |
| 380 mg/mL | 25.8 | 7.5 × 10−9 (0.4) | ** | 8.5(3) | |
| †† | 440 mg/mL | 25.8 | 5.4 × 10−9 (0.4) | ** | 10.4(4) |
D0, concentration extrapolated to 0; MW, molecular mass.
Measured by pulsed field gradient NMR as described in SI Materials and Methods (30 °C).
Hydrodynamic radius (RH) calculated from measured diffusion coefficient in buffer along with diffusion of acetate (30 °C) (SI Materials and Methods).
Product of square of order parameter for backbone amide, S2, and residue-specific overall tumbling time, τC, averaged over residues for which data is available (30 °C).
Sample obtained from the dilute phase of phase-separated Ddx4
Extrapolated from self-diffusion data as a function of concentration to zero concentration.
Relaxation data not measured.
Hydrodynamic radius cannot be accurately extracted from diffusion measurements on concentrated samples because of elevated viscosity. All estimates of RH make use of dilute Ddx4 samples.
A lower NaCl concentration was used (7.5 mM) relative to all other Ddx4 samples to achieve a higher protein concentration in the condensed phase.